Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement

被引:74
作者
Yazdany, Jinoos [1 ]
Bansback, Nick [2 ]
Clowse, Megan [3 ]
Collier, Deborah [4 ]
Law, Karen [5 ]
Liao, Katherine P. [6 ]
Michaud, Kaleb [7 ,8 ]
Morgan, Esi M. [9 ]
Oates, James C. [10 ]
Orozco, Catalina [11 ]
Reimold, Andreas [12 ,13 ]
Simard, Julia F. [14 ]
Myslinski, Rachel [15 ]
Kazi, Salahuddin [13 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] Duke Univ, Durham, NC USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] Univ Nebraska Med Ctr, Omaha, NE USA
[8] Natl Data Bank Rheumat Dis, Wichita, KS USA
[9] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA
[10] Med Univ South Carolina, Charleston, SC 29425 USA
[11] Rheumatol Associates, Dallas, TX USA
[12] Dallas Vet Affairs Med Ctr, Dallas, TX USA
[13] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[14] Stanford Sch Med, Stanford, CA USA
[15] Amer Coll Rheumatol, 60 Execut Pk S,Suite 150, Atlanta, GA 30329 USA
关键词
D O I
10.1002/acr.23089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The Rheumatology Informatics System for Effectiveness (RISE) is a national electronic health record (EHR)enabled registry. RISE passively collects data from EHRs of participating practices, provides advanced quality measurement and data analytic capacities, and fulfills national quality reporting requirements. Here we report the registry's architecture and initial data, and we demonstrate how RISE is being used to improve the quality of care. Methods. RISE is a certified Centers for Medicare and Medicaid Services Qualified Clinical Data Registry, allowing collection of data without individual patient informed consent. We analyzed data between October 1, 2014 and September 30, 2015 to characterize initial practices and patients captured in RISE. We also analyzed medication use among rheumatoid arthritis (RA) patients and performance on several quality measures. Results. Across 55 sites, 312 clinicians contributed data to RISE; 72% were in group practice, 21% in solo practice, and 7% were part of a larger health system. Sites contributed data on 239,302 individuals. Among the subset with RA, 34.4% of patients were taking a biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) at their last encounter, and 66.7% were receiving a nonbiologic DMARD. Examples of quality measures include that 55.2% had a disease activity score recorded, 53.6% a functional status score, and 91.0% were taking a DMARD in the last year. Conclusion. RISE provides critical infrastructure for improving the quality of care in rheumatology and is a unique data source to generate new knowledge. Data validation and mapping are ongoing and RISE is available to the research and clinical communities to advance rheumatology.
引用
收藏
页码:1866 / 1873
页数:8
相关论文
共 3 条
  • [1] The Triple Aim: Care, health, and cost
    Berwick, Donald M.
    Nolan, Thomas W.
    Whittington, John
    [J]. HEALTH AFFAIRS, 2008, 27 (03) : 759 - 769
  • [2] Centers for Medicare and Medicaid Services, 2016, QUAL CLIN DAT REG RE
  • [3] Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures
    Yazdany, Jinoos
    Robbins, Mark
    Schmajuk, Gabriela
    Desai, Sonali
    Lacaille, Diane
    Neogi, Tuhina
    Singh, Jasvinder A.
    Genovese, Mark
    Myslinski, Rachel
    Fisk, Natalie
    Francisco, Melissa
    Newman, Eric
    [J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (11) : 1579 - 1590